학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 721건 | 목록 1~20
Academic Journal
Hlevnjak M; Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Heublein S; Department of Gynecology and Obstetrics, University Hospital Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.; Thewes V; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Wagener L; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Pixberg C; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Fremd C; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Michel L; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Maurer C; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Buschhorn L; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Dikow N; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Feng F; Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Fröhling S; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Herold-Mende C; Division of Experimental Neurosurgery, Department of Neurosurgery, Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Germany.; Hirsch S; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Division of Pediatric Neurooncology, DKFZ; German Cancer Consortium (DKTK), Partner Site Heidelberg, Heidelberg, Germany.; Hong C; Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hübschmann D; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Jassowicz L; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Experimental Neurosurgery, Department of Neurosurgery, Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Germany.; Kozyulina P; Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Pfütze K; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Experimental Neurosurgery, Department of Neurosurgery, Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Germany.; Sample Processing Laboratory, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Schlenk RF; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; NCT Clinical Trial Center, National Center for Tumor Diseases (NCT), NCT Heidelberg a Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the HeidelbergUniversity, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Internal Medicine V, University Hospital, Heidelberg, Germany.; Sinn HP; Institute for Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Smetanay K; Department of Gynecology and Obstetrics, University Hospital Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Springfeld C; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Stenzinger A; Institute for Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Wagner C; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Obstetrics and Gynecology, University Hospital, LMU, Munich, Germany.; Wolf S; Next Generation Sequencing Core Facility, German Cancer Research Center DKFZ, Heidelberg, Germany.; Trumpp A; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Jäger D; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Zivanovic O; Department of Gynecology and Obstetrics, University Hospital Heidelberg, Heidelberg, Germany.; Zapatka M; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Schneeweiss A; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Lichter P; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Academic Journal
Lanzafame H; Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany; helena.lanzafame@uk-essen.de.; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Heilig CE; Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, a partnership between German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany.; Wardelmann E; Gerhard-Domagk-Institute of Pathology, University of Münster, Münster, Germany.; Desaulniers M; Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Department of Nuclear Medicine and Radiobiology, Université de Sherbrooke, Sherbrooke, Quebec, Canada.; Pabst KM; Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Mavroeidi IA; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; Pretzell I; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; Fragoso Costa P; Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Nader M; Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Leyser S; Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Schuler M; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; National Center for Tumor Diseases West, Essen, Germany.; Bauer S; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; National Center for Tumor Diseases West, Essen, Germany.; Siveke JT; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany; and.; Division of Solid Tumor Translational Oncology, German Cancer Consortium, Partner Site Essen, Essen, Germany; and.; German Cancer Research Center, Heidelberg, Germany.; Kamkar L; Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, a partnership between German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany.; Kreutzfeldt S; Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, a partnership between German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany.; Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, a partnership between German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany.; Mühl S; Gerhard-Domagk-Institute of Pathology, University of Münster, Münster, Germany.; Herrmann K; Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; National Center for Tumor Diseases West, Essen, Germany.; Fendler WP; Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Hamacher R; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Academic Journal
Hartmann M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) , NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Schönung M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) , NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Rajak J; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.; Maurer V; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) , NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; European Molecular Biology Laboratory Hamburg, Hamburg, Germany.; Centre for Structural Systems Biology (CSSB), Hamburg, Germany.; Hai L; Bioinformatics and Omics Data Analytics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bauer K; scOPEN Lab, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hakobyan M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) , NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Stäble S; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) , NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Langstein J; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) , NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Jardine L; Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; Roelz R; Department of Neurosurgery, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Bohler S; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Khabirova E; Wellcome Sanger Institute , Hinxton, United Kingdom.; Maag AH; Institute of Experimental Cancer Research, University Hospital of Ulm, Ulm, Germany.; Vonficht D; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Lebrecht D; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Bernt KM; Division of Pediatric Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Tan K; Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania.; Chen C; Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania.; Alikarami F; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Meyer J; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, California.; Wang J; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.; Boch T; Department of Hematology and Oncology, Heidelberg University, University Hospital Mannheim, Mannheim, Germany.; Flore V; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) , NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Lutsik P; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Milsom MD; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Experimental Hematology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Raffel S; Department of Medicine, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; Buske C; Institute of Experimental Cancer Research, University Hospital of Ulm, Ulm, Germany.; Haas S; Precision Healthcare University Research Institute, Queen Mary University of London, London, United Kingdom.; Berlin Institute of Health (BIH), Charité - Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center in the Helmholtz Association, Berlin, Germany.; Haniffa M; Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; Wellcome Sanger Institute , Hinxton, United Kingdom.; Mallm JP; scOPEN Lab, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Behjati S; Wellcome Sanger Institute , Hinxton, United Kingdom.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom.; Bonder MJ; Division of Computational Genomics and Systems Genetics, German Cancer Research Center, Heidelberg, Germany.; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.; Fröhling S; National Center for Tumor Diseases (NCT) , NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Stieglitz E; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, California.; Niemeyer CM; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), partner site Freiburg, a partnership between DKFZ and University Medical Center Freiburg, Freiburg, Germany.; Hey J; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German-Israeli Helmholtz International Research School in Cancer Biology, Heidelberg, Germany.; Flotho C; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), partner site Freiburg, a partnership between DKFZ and University Medical Center Freiburg, Freiburg, Germany.; Plass C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Erlacher M; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.; German Cancer Consortium (DKTK), partner site Freiburg, a partnership between DKFZ and University Medical Center Freiburg, Freiburg, Germany.; Schlesner M; Bioinformatics and Omics Data Analytics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Applied Computer Sciences, Biomedical Informatics, Data Mining and Data Analytics, University of Augsburg, Augsburg, Germany.; Lipka DB; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) , NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Faculty of Medicine, Otto-von-Guericke-University, Magdeburg, Germany.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE
Academic Journal
Lanzafame H; Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany; helena.lanzafame@uk-essen.de.; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Mavroeidi IA; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; Pabst KM; Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Fragoso Costa P; Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany.; Schuler M; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; National Center for Tumor Diseases, NCT West, Essen, Germany.; Bauer S; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; National Center for Tumor Diseases, NCT West, Essen, Germany.; Kurth J; Department of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany.; Heuschkel M; Department of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany.; Siveke JT; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; National Center for Tumor Diseases, NCT West, Essen, Germany.; Bridge Institute of Experimental Tumor Therapy and Division of Solid Tumor Translational Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; Herrmann K; Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; National Center for Tumor Diseases, NCT West, Essen, Germany.; Kostbade K; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; Kersting D; Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Leyser S; Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany.; National Center for Tumor Diseases, NCT Heidelberg, Heidelberg, Germany.; German Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany; and.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Heilig CE; Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany.; National Center for Tumor Diseases, NCT Heidelberg, Heidelberg, Germany.; German Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany; and.; Hamacher R; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; National Center for Tumor Diseases, NCT West, Essen, Germany.; Fendler WP; Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.
Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Academic Journal
Ringborg U; European Academy of Cancer Sciences, Stockholm, Sweden.; Cancer Center Karolinska, Karolinska University Hospital, Stockholm, Sweden.; von Braun J; Pontifical Academy of Sciences, Vatican City, Italy.; Bonn University, Germany.; Celis J; European Academy of Cancer Sciences, Stockholm, Sweden.; Berns A; European Academy of Cancer Sciences, Stockholm, Sweden.; The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Baumann M; European Academy of Cancer Sciences, Stockholm, Sweden.; German Cancer Research Center, Heidelberg, Germany.; Albreht T; National Institute of Public Health, Ljubljana, Slovenia.; Abou-Zeid N; Fondation ARC, Villejuif Cedex, France.; Bagnato V; University of Sao Paulo, Brazil.; Texas A&M University, College Station, TX, USA.; Brandts C; UCT University Cancer Center, Frankfurt, University Hospital Frankfurt, Germany.; Chen CJ; European Academy of Cancer Sciences, Stockholm, Sweden.; Academia Sinica, Taipei, Taiwan.; di Pietro M; Early Cancer Institute, University of Cambridge, UK.; Dosanjh M; University of Oxford, UK.; Dubois T; INCa, National Cancer Institute, Boulogne Billancourt, France.; Eggermont A; European Academy of Cancer Sciences, Stockholm, Sweden.; University Medical Center Utrecht & Princess Máxima Center for Pediatric Oncology, The Netherlands.; Eggert A; European Academy of Cancer Sciences, Stockholm, Sweden.; Charité, Berlin, Germany.; Ernberg I; Cancer Center Karolinska, Karolinska University Hospital, Stockholm, Sweden.; Karolinska Institutet, Stockholm, Sweden.; Faithfull S; European Academy of Cancer Sciences, Stockholm, Sweden.; Trinity College Dublin, The University of Dublin, Ireland.; Förner J; Patient Advisory Council of the German Cancer Research Center (DKFZ) and NCT Patient Research Council, Heidelberg, Germany.; Fröhling S; German Cancer Research Center, Heidelberg, Germany.; Heitor M; European Academy of Cancer Sciences, Stockholm, Sweden.; Centre for Innovation, Tech. & Policy Research, IN+@IS Tecnico, University of Lisbon, Portugal.; Hood L; Phenome Health and the Institute of Systems Biology, Seattle, WA, USA.; Buck Institute for Research on Aging, Novato, CA, USA.; Jiang W; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Jönsson B; European Academy of Cancer Sciences, Stockholm, Sweden.; Stockholm School of Economics, Sweden.; Kannan R; Cachar Cancer Hospital and Research Centre (CCHRC), India.; Leptin M; European Research Council, Brussels, Belgium.; Li S; Department of Clinical Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.; Lindgren P; The Swedish Institute for Health Economics, Stockholm, Sweden.; Lowy D; National Cancer Institute, Bethesda, MD, USA.; Ma J; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Markham A; European Academy of Cancer Sciences, Stockholm, Sweden.; University of Leeds, UK.; Nagy P; Department of Molecular Immunology and Toxicology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, Hungary.; Oberst S; Organisation of European Cancer Institutes, OECI, Brussels, Belgium.; Parker MI; University of Cape Town, Faculty of Health Sciences, South Africa.; Rodin D; Princess Margaret Cancer Center, Toronto, Canada.; Ryan K; Molecular Oncology, Cambridge, UK.; Cancer Research UK Scotland Institute Glasgow, UK.; School of Cancer Sciences, University of Glasgow, UK.; Schüz J; European Academy of Cancer Sciences, Stockholm, Sweden.; International Agency for Research on Cancer, Lyon, France.; Sullivan R; European Academy of Cancer Sciences, Stockholm, Sweden.; Institute of Cancer Policy, King's College, London, UK.; Tabernero J; European Academy of Cancer Sciences, Stockholm, Sweden.; Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Turkson P; Pontifical Academy of Sciences, Vatican City, Italy.; Várhelyi O; EU Commissioner for Health and Animal Welfare, Brussels, Belgium.; Varmus H; Weill Cornell Medicine, New York, USA.; Wang C; Department of Clinical Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.; Weiderpass E; European Academy of Cancer Sciences, Stockholm, Sweden.; International Agency for Research on Cancer, Lyon, France.; Wilking N; Karolinska Institutet, Stockholm, Sweden.
Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Academic Journal
Hübschmann D; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Innovation and Service Unit for Bioinformatics and Precision Medicine, DKFZ, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Kreutzfeldt S; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Roth B; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Glocker K; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Medical Genetics Center, Munich, Germany.; Schoop J; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Oeser L; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Hausmann S; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Koch C; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Uhrig S; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.; Hüllein J; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.; Hutter B; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.; Fröhlich M; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.; Heilig CE; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Teleanu MV; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Lipka DB; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Kerle IA; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; DKTK, Partner Site Dresden, Dresden, Germany.; Baude-Müller A; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Beck K; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Heining C; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; DKTK, Partner Site Dresden, Dresden, Germany.; Glimm H; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; DKTK, Partner Site Dresden, Dresden, Germany.; Ückert F; Institute for Applied Medical Informatics, Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Knurr A; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Fröhling S; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; Horak P; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany. peter.horak@nct-heidelberg.de.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany. peter.horak@nct-heidelberg.de.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Zuljan E; Core Unit Bioinformatics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.; von der Emde B; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Piwonski I; Department of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Pestana A; Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Klinghammer K; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany.; Mock A; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Institute of Pathology, Ludwig-Maximilians-University Munich, München, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Horak P; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Heining C; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany.; Klauschen F; Department of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Institute of Pathology, Ludwig-Maximilians-University Munich, München, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.; Pretzell I; West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK), partner site Essen, Essen, Germany.; Boerries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner site Freiburg, a partnership between DKFZ and Medical Center - University of Freiburg, Freiburg, Germany.; Brandts CH; Goethe University Frankfurt, University Hospital, Department of Medicine, Hematology/Oncology & University Cancer Center Frankfurt (UCT), Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt, Frankfurt, Germany.; Kreutzfeldt S; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Teleanu MV; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Hübschmann D; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Morris LGT; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Heiland M; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany.; Department of Oral and Maxillofacial Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Keller U; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany.; Conrad T; Genomics Technology Platform, Berlin Institute of Health at Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Glimm H; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany.; Fröhling S; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Ochsenreither S; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany.; Keilholz U; Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany.; Blanc E; Core Unit Bioinformatics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.; Beule D; Core Unit Bioinformatics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.; Rieke DT; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. damian.rieke@charite.de.; Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. damian.rieke@charite.de.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany. damian.rieke@charite.de.; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany. damian.rieke@charite.de.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Zech HB; Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Mildred-Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Schafhausen P; 2nd Department of Medicine (Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology) and University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Ramke L; Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Velthaus JL; 2nd Department of Medicine (Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology) and University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Kreutzfeldt S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between German Cancer Research Center (DKFZ) and Heidelberg University Hospital, 01307 Heidelberg, Germany.; Hübschmann D; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between German Cancer Research Center (DKFZ) and Heidelberg University Hospital, 01307 Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, 69120 Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, 69120 Heidelberg, Germany.; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Innovation and Service Unit for Bioinformatics and Precision Medicine, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem Cell Technology and Experimental Medicine, 69120 Heidelberg, Germany.; Rothkamm K; Department of Radiotherapy & Radiation Oncology, Hubertus Wald Tumorzentrum-University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Bokemeyer C; 2nd Department of Medicine (Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology) and University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Hoffmann AS; Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between German Cancer Research Center (DKFZ) and Heidelberg University Hospital, 01307 Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, 69120 Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, 69120 Heidelberg, Germany.; Glimm H; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center Dresden, a Partnership Between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, Dresden University of Technology (TUD), and Helmholtz-Zentrum Dresden-Rossendorf, 01307 Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD, 01069 Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, 01307 Dresden, Germany.; Translational Functional Cancer Genomics, German Cancer Consortium (DKFZ), 69120 Heidelberg, Germany.; Betz CS; Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Kriegs M; Department of Radiotherapy & Radiation Oncology, Hubertus Wald Tumorzentrum-University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; UCCH Kinomics Core Facility, Hubertus Wald Tumorzentrum-University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Christopeit M; 2nd Department of Medicine (Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology) and University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
Academic Journal
Lutz R; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Poos AM; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Solé-Boldo L; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany.; Precision Healthcare University Research Institute, Queen Mary University of London, London, UK.; John L; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Wagner J; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Prokoph N; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Baertsch MA; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Vonficht D; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Palit S; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany.; Brobeil A; Department of Pathology, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Tissue Bank of the National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.; Mechtersheimer G; Department of Pathology, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Hildenbrand N; Department of Orthopaedics, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Hemmer S; Department of Orthopaedics, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Steiger S; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany.; Horn S; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; Institute of Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Pepke W; Department of Orthopaedics, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Spranz DM; Department of Orthopaedics, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Rehnitz C; Department of Radiology, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Sant P; Single Cell Open Lab, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Mallm JP; Single Cell Open Lab, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Friedrich MJ; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Reichert P; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Huhn S; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Trumpp A; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Rippe K; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany.; Haghverdi L; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Müller-Tidow C; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Hübschmann D; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Goldschmidt H; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; GMMG-Study Group at Heidelberg University Hospital, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Willimsky G; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; Institute of Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Sauer S; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Raab MS; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Haas S; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany.; Precision Healthcare University Research Institute, Queen Mary University of London, London, UK.; German Cancer Consortium (DKTK), partner site Berlin, Berlin, Germany.; Weinhold N; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Fröhling, K -P
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어